| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1822 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 283 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Cardiotoxicity associated with carfilzomib: systematic review and meta-analysis C Shah, R Bishnoi, A Jain, H Bejjanki, S Xiong, Y Wang, F Zou, JS Moreb Leukemia & lymphoma 59 (11), 2557-2569, 2018 | 68 | 2018 |
| Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients R Bishnoi, R Bajwa, AJ Franke, WP Skelton, Y Wang, NM Patel, ... Experimental Hematology & Oncology 6, 1-14, 2017 | 55 | 2017 |
| Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint … R Bishnoi, YR Hong, C Shah, A Ali, WP Skelton IV, J Huo, NH Dang, ... Cancer medicine 8 (8), 3918-3927, 2019 | 48 | 2019 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| A multi‑center retrospective analysis of the effect of DPP4 inhibitors on progression‑free survival in advanced airway and colorectal cancers A Ali, A Fuentes, WP Skelton Iv, Y Wang, S McGorray, C Shah, R Bishnoi, ... Molecular and clinical oncology 10 (1), 118-124, 2019 | 37 | 2019 |
| Safety and efficacy of dual versus triple antithrombotic therapy in patients undergoing percutaneous coronary intervention N Agarwal, A Jain, AN Mahmoud, R Bishnoi, H Golwala, A Karimi, ... The American journal of medicine 130 (11), 1280-1289, 2017 | 37 | 2017 |
| Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era C Shah, LK Mramba, R Bishnoi, H Bejjanki, HS Chhatrala, SR Chandana Journal of Gastrointestinal Oncology 8 (5), 789, 2017 | 34 | 2017 |
| The role of a best practice alert in the electronic medical record in reducing repetitive lab tests H Bejjanki, LK Mramba, SG Beal, N Radhakrishnan, R Bishnoi, C Shah, ... ClinicoEconomics and Outcomes Research, 611-618, 2018 | 32 | 2018 |
| Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis R Bishnoi, Z Xie, C Shah, J Bian, HS Murthy, JR Wingard, N Farhadfar Cancer medicine 10 (1), 70-78, 2021 | 31 | 2021 |
| Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models X Du, J Min, CP Shah, R Bishnoi, WR Hogan, DJ Lemas International journal of medical informatics 139, 104140, 2020 | 31 | 2020 |
| Impact of DPP4 inhibitors in survival of patients with prostate, pancreas, and breast cancer C Shah, YR Hong, R Bishnoi, A Ali, WP Skelton IV, LH Dang, J Huo, ... Frontiers in Oncology 10, 405, 2020 | 28 | 2020 |
| Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials C Shah, R Bishnoi, Y Wang, F Zou, H Bejjanki, S Master, JS Moreb Oncotarget 9 (34), 23704, 2018 | 26 | 2018 |
| Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database CP Shah, LK Mramba, R Bishnoi, A Unnikrishnan, JM Duff, SR Chandana Journal of gastrointestinal oncology 10 (5), 869, 2019 | 24 | 2019 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer cell 38 (6), 761-766, 2020 | 18 | 2020 |
| Analysis of overall survival in patients with multiple primary malignancies: a single-center experience WP Skelton IV, A Ali, MN Skelton, R Federico, R Bosse, TC Nguyen, ... Cureus 11 (4), 2019 | 16 | 2019 |
| Osborne-Cotterill lesion a forgotten injury: review article and case report DG Vargas, S Woodcock, GF Porto, JC Gonzalez Clinics in shoulder and elbow 23 (1), 27, 2020 | 13 | 2020 |
| Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction MW Khan, S Kurian, R Bishnoi International journal of general medicine, 103-106, 2016 | 13 | 2016 |
Chintan P. ShahMD Anderson Cancer CenterVerified email at mdanderson.org
